chikungunya virus infection
Showing 1 - 18 of 18
Chikungunya Virus Infection Trial (VLA1553 full dose, VLA1553 half dose, Control)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553 full dose
- +2 more
- (no location specified)
Oct 24, 2023
Chikungunya Virus Infection Trial (VLA1553)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553
- (no location specified)
Aug 31, 2023
Chikungunya Virus Infection Trial (PXVX0317 vaccine booster, Placebo booster)
Not yet recruiting
- Chikungunya Virus Infection
- PXVX0317 vaccine booster
- Placebo booster
- (no location specified)
Aug 18, 2023
Chikungunya Virus Infection Trial in San Juan (V184, Placebo)
Completed
- Chikungunya Virus Infection
- V184
- Placebo
-
San Juan, Puerto RicoSan Juan Hospital, Research Unit
Sep 6, 2022
Chikungunya Virus Infection Trial in Lenexa, Durham (Placebo, SAR440894)
Recruiting
- Chikungunya Virus Infection
- Placebo
- SAR440894
-
Lenexa, Kansas
- +1 more
Aug 18, 2022
Chikungunya Virus Infection Trial in United States (VLA1553, Placebo)
Completed
- Chikungunya Virus Infection
- VLA1553
- Placebo
-
Chandler, Arizona
- +43 more
Jul 25, 2022
Chikungunya Virus Infection Trial in United States (Biological Vaccine VLA1553)
Completed
- Chikungunya Virus Infection
- Biological Vaccine VLA1553
-
Coral Gables, Florida
- +11 more
Jan 31, 2022
Chikungunya Virus Infection Trial in Lenexa, Kansas City, West Jordan (CHIKV VLP/unadjuvanted, CHIKV VLP/adjuvanted, Placebo)
Completed
- Chikungunya Virus Infection
- CHIKV VLP/unadjuvanted
- +2 more
-
Lenexa, Kansas
- +2 more
Oct 12, 2021
Chikungunya Virus Infection Trial in Austria, Germany (MV-CHIK low dose, MV-CHIK high dose, Priorix®)
Completed
- Chikungunya Virus Infection
- MV-CHIK low dose
- +3 more
-
Graz, Austria
- +3 more
Oct 15, 2021
Chikungunya Virus Infection Trial in United States (VLA1553)
Enrolling by invitation
- Chikungunya Virus Infection
- VLA1553
-
Phoenix, Arizona
- +10 more
Oct 21, 2021
Chikungunya Virus Infection Trial in Saint-Pierre (OPHTHALMOLOGICAL ASSESSMENT, NEUROPSYCHOLOGICAL ASSESSMENT)
Recruiting
- Chikungunya Virus Infection
- OPHTHALMOLOGICAL ASSESSMENT
- NEUROPSYCHOLOGICAL ASSESSMENT
-
Saint-Pierre, RéunionCHU de La Réunion
Jun 2, 2021
Dengue Fever Trial in Belo Horizonte (Brazilian National Dengue Control Program, Wolbachia-infected Aedes aegypti)
Recruiting
- Chikungunya Virus Infection
- +3 more
- Brazilian National Dengue Control Program
- Wolbachia-infected Aedes aegypti
-
Belo Horizonte, Minas Gerais, BrazilUniversidade Federal de Minas Gerais, Instituto de Ciencias Biol
May 27, 2021
Chikungunya Virus Infection Trial in Atlanta, Iowa City, Houston (Placebo, VRC-CHKVLP059-00-VP)
Completed
- Chikungunya Virus Infection
- Placebo
- VRC-CHKVLP059-00-VP
-
Atlanta, Georgia
- +2 more
Nov 25, 2020
Chikungunya Virus Infection Trial in Worldwide (VRC-CHKVLP059-00-VP, VRC-PBSPLA043-00-VP)
Completed
- Chikungunya Virus Infection
- VRC-CHKVLP059-00-VP
- VRC-PBSPLA043-00-VP
-
Santo Domingo, Dominican Republic
- +5 more
Oct 20, 2020
Chikungunya Virus Infection Trial in Pointe-à-Pitre (Wait-list group, Yoga group)
Terminated
- Chikungunya Virus Infection
- Wait-list group
- Yoga group
-
Pointe-à-Pitre, GuadeloupeMouffias' Medical Center in Guadeloupe.
Jul 1, 2020
Seroprevalence of Chikungunya at End of First Chikungunya
Completed
- HIV Infections
- Chikungunya Virus Infection
- Biological sample collection
-
Pointe-à-Pitre, Guadeloupe, France
- +1 more
Jul 25, 2016
Viral Vaccines, Chikungunya Fever, Chikungunya Virus Infection Trial run by the NIAID (VRC-CHKVLP059-00-VP)
Completed
- Viral Vaccines
- +2 more
- VRC-CHKVLP059-00-VP
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 9, 2016
Chikungunya Virus Infection Trial in Basse-Terre, Cayenne, Fort-de-France (anti-CHIKV hyperimmune immunoglobulins)
Unknown status
- Chikungunya Virus Infection
- anti-CHIKV hyperimmune immunoglobulins
-
Basse-Terre, Guadeloupe, France
- +2 more
Oct 31, 2014